Galectin Therapeutics
GALT
GALT
92 hedge funds and large institutions have $12.6M invested in Galectin Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 12 closing their positions.
Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
18
Reduced
29
Closed
12
Calls
$757K
Puts
$2.57M
Net Calls
-$1.81M
Net Calls Change
-$72K
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$1.73M |
2 |
CCB
2
Cutter & Co Brokerage
Ballwin,
Missouri
|
$0 |
3 |
3
Northern Trust
Chicago,
Illinois
|
$208K |
4 |
4
Barclays
London,
United Kingdom
|
$12K |
5 |
5
Morgan Stanley
New York
|
$299K |